A. Elimadi et al., COMPARISON OF THE EFFECTS OF CYCLOSPORINE-A AND TRIMETAZIDINE ON CA2-DEPENDENT MITOCHONDRIAL SWELLING(), Fundamental and clinical pharmacology, 11(5), 1997, pp. 440-447
Cyclosporine A (CsA) is a known potent inhibitor of pro-oxidant-induce
d mitochondrial swelling. In the present study we show that CsA's effe
ct is only transient when the liver mitochondrial swelling is induced
by Ca2+ plus tert-butylhydroperoxide (t-BH). After an initial inhibiti
on, swelling is worsened by CsA as evidenced by an extent of mitochond
rial swelling that exceeds that of the control. Unlike CsA, trimetazid
ine (TMZ), an anti-ischemic drug decreases both the extent and the rat
e of the swelling with an IC50 value of 214 +/- 24 mu M. Its inhibitio
n effect on the initial swelling rate mimicks that of CsA but the mech
anism may be independent. During long-term swelling, TMZ counteracts t
he worsening effect of CsA. The inhibition of swelling induced by TMZ
is assessed by the fact that TMZ significantly increases the EC50 of C
a2+-induced mitochondrial swelling (46.6 +/- 6.0 to 85 +/- 10 mu M, P
< 0.01), without affecting its cooperativity. Apparently, TMZ seems to
behave like trifluoperazine (TFP), a phospholipase A(2) inhibitor tha
t, under our experimental conditions, inhibits the mitochondrial swell
ing induced by Ca2+ and t-BH with an IC50 value of 25 +/- 10 mu M. Bot
h drugs are able to protect mitochondria from both phases (early and l
ate) of the swelling, especially the late, which is enhanced in the pr
esence of CsA. TFP and other phospholipase A(2) inhibitors were able t
o displace [H-3]TMZ from its mitochondrial binding sites whereas CsA w
as ineffective. We suggest that TMZ, like TFP, inhibits the CsA insens
itive mechanism involved in the swelling process which is responsible
for the worsening effect observed in the presence of CsA when the swel
ling is generated by Ca2+ and t-BH.